Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome

NCT00426543 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.

NCT NCT00426543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00426543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome
Lead sponsor
University of Copenhagen
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2007
Completion date
August 31, 2010
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue, hyposalivation, keratoconjunctivitis sicca, primary sjögren's syndrome, xerostomia